GenNx360 Capital Partners, a New York City-based private equity firm investing in middle-market B2B services and industrial firms, has made a growth investment in Tensentric.
Tensentric is a provider of outsourced design, engineering, prototyping, and assembly services for medical technology, in-vitro diagnostic, and life sciences firms. The firm is known for its differentiated portfolio of engineers and experience in industry projects. Tensentric represents GenNx360’s seventh platform investment from its Fund III as the firm continues to execute its proactive investment strategy.
“We are very enthusiastic to welcome GenNx360 as our partner in what marks an important milestone in Tensentric’s evolution,”said Wade Lukianow, Tensentric’s co-founder and CEO. “With their growth-focused mindset and track record of successfully scaling services platforms, GenNx360’s partnership will help us serve our customers better as they look to expedite their product development initiatives.”
“GenNx360 will undoubtedly help us continue to offer our clients the best-in-class solutions and execute on the next phase of our growth strategy,” added Jeff Gentry, Tensentric’s co-founder and COO.